Skip to main content
Clinical Trials/JPRN-UMIN000010091
JPRN-UMIN000010091CompletedPhase 4

A prospective randomized clinical trial, the effect of long acting CCBs in post-acute myocardial infarction patients - ACROSS-AMI (ACh-induced Coronary Spasm Study - Nifedipine and Benidipine After Acute Myocardial Infarction)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University0 sites97 target enrollmentStarted: February 21, 2013Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
97

Study Overview

Brief Summary

There were no significant differences in the baseline clinical characteristics except younger age in nifedipine compared with benidipine groups. In age-adjusted model, the difference of dilator response to ISDN between initial and follow-up ACh tests was almost identical between 2 groups. However, the difference of constrictor response to ACh was significantly improved in the nifedipine rather than benidipine groups.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 85years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with 1) Unstable angina (UAP) 2) Triple vessel disease 3) Left ventricular ejection fraction <40% 4) Chronic atrial fibrillation 5) Severe hepatic dysfunction 6) Low tolerability of DHP-CCB 7) A history of DES implantation 8) Patients who were recognized by the chief physician to be inappropriate for study participation

Investigators

Sponsor
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University

Similar Trials

A prospective randomized clinical trial,... | Clinical Trial